The drug discovery startup, co-founded by research technology producer Atomwise, has pulled in $14.5m through a round led by DCVC Bio.

X-37, a US-based drug discovery company co-founded by biotech research technology producer Atomwise, has closed a $14.5m series A round led by DCVC Bio, a fund operated by venture capital firm Data Collective. DCVC Bio was joined in the round by VC funds Alpha Intelligence Capital and Hemi Ventures. Founded in 2018, X-37 is working…

The rest of this content is only accessible to Corporate Venturing: News, Data, and Events - Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.